• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经历首过效应和线性可逆代谢的口服药物的平均驻留时间。

Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

作者信息

Cheng H, Jusko W J

机构信息

Department of Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486.

出版信息

Pharm Res. 1993 Jan;10(1):8-13. doi: 10.1023/a:1018904509178.

DOI:10.1023/a:1018904509178
PMID:8430064
Abstract

Equations for the mean residence times in the body (MRT) and AUMC/AUC of a drug and its metabolite have been derived for an oral drug undergoing first-pass and linear reversible metabolism. The mean residence times of the drug or interconversion metabolite in the body after oral drug are described by equations which include the mean absorption time (MAT), the mean residence times of the drug or metabolite in the body after intravenous administration of the drug, the fractions of the dose entering the systemic circulation as the parent drug and metabolite, and the systemically available fractions of the drug (Fpp) or metabolite (Fpm). Similarly, the AUMC/AUC of the drug and metabolite after oral drug can be related to the MAT, ratios of the fraction of the dose entering the systemic circulation to the systemically available fraction, the first-time fractional conversion of each compound, and AUMC/AUC ratios after separate intravenous administration of each compound. The Fpp and Fpm values, in turn, are related to the first-pass availabilities of both drug and metabolite and the first-time fractional conversion fractions. The application of these equations to a dual reversible two-compartment model is illustrated by computer simulations.

摘要

对于经历首过效应和线性可逆代谢的口服药物,已推导得出药物及其代谢物在体内的平均驻留时间(MRT)以及AUMC/AUC的方程。口服药物后,药物或相互转化代谢物在体内的平均驻留时间由包含平均吸收时间(MAT)、静脉注射药物后药物或代谢物在体内的平均驻留时间、以母体药物和代谢物形式进入体循环的剂量分数以及药物(Fpp)或代谢物(Fpm)的全身可利用分数的方程来描述。同样,口服药物后药物和代谢物的AUMC/AUC可与MAT、进入体循环的剂量分数与全身可利用分数的比值、每种化合物的首次分数转化率以及每种化合物单独静脉注射后的AUMC/AUC比值相关。反过来,Fpp和Fpm值与药物和代谢物的首过效应以及首次分数转化分数有关。通过计算机模拟说明了这些方程在双可逆二室模型中的应用。

相似文献

1
Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.经历首过效应和线性可逆代谢的口服药物的平均驻留时间。
Pharm Res. 1993 Jan;10(1):8-13. doi: 10.1023/a:1018904509178.
2
The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
Biopharm Drug Dispos. 1995 Dec;16(9):791-6. doi: 10.1002/bdd.2510160908.
3
A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
Biopharm Drug Dispos. 1993 Jan;14(1):71-9. doi: 10.1002/bdd.2510140107.
4
Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
Biopharm Drug Dispos. 1995 May;16(4):259-67. doi: 10.1002/bdd.2510160402.
5
Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.
Pharm Res. 1990 Jan;7(1):59-63. doi: 10.1023/a:1015887626171.
6
Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.经历线性可逆代谢、组织分布以及从中枢室进行线性或非线性消除的药物的平均驻留时间和分布容积。
Pharm Res. 1991 Apr;8(4):508-11. doi: 10.1023/a:1015811514050.
7
A general model of metabolite kinetics following intravenous and oral administration of the parent drug.母体药物静脉注射和口服给药后代谢物动力学的一般模型。
Biopharm Drug Dispos. 1988 Mar-Apr;9(2):159-76. doi: 10.1002/bod.2510090205.
8
Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.用于估算经历可逆代谢的药物在体内的稳态分布容积和平均驻留时间的恒速静脉输注方法。
Pharm Res. 1990 Jun;7(6):628-32. doi: 10.1023/a:1015874329265.
9
Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.平均停留时间概念在具有非瞬时输入和非线性消除的药代动力学系统中的应用。
Pharm Res. 1989 Jan;6(1):4-12. doi: 10.1023/a:1015883131875.
10
The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.样本合并方法在药代动力学研究中用于确定曲线下面积(AUC)、一阶矩曲线下面积(AUMC)和平均驻留时间的应用。
Fundam Clin Pharmacol. 2005 Jun;19(3):347-54. doi: 10.1111/j.1472-8206.2005.00329.x.

本文引用的文献

1
A liner mode of reversible metabolism and its application to bioavailability assessment.一种可逆代谢的线性模式及其在生物利用度评估中的应用。
J Pharmacokinet Biopharm. 1981 Dec;9(6):693-709. doi: 10.1007/BF01070901.
2
Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
Res Commun Chem Pathol Pharmacol. 1981 Jun;32(3):387-405.
3
The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.统计矩理论在体内溶出时间和吸收时间评估中的应用。
J Pharmacokinet Biopharm. 1980 Oct;8(5):509-34. doi: 10.1007/BF01059549.
4
LAGRAN program for area and moments in pharmacokinetic analysis.药代动力学分析中用于面积和矩的LAGRAN程序。
Comput Programs Biomed. 1983 Jun;16(3):203-16. doi: 10.1016/0010-468x(83)90082-x.
5
Generalized rates of transfer in open systems of pools in the steady state.
J Clin Endocrinol Metab. 1966 Dec;26(12):1346-54. doi: 10.1210/jcem-26-12-1346.
6
The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.循环代谢系统基本清除率、容积和驻留时间参数的测定:甲基泼尼松龙和甲基泼尼松在兔体内的可逆代谢
J Pharmacokinet Biopharm. 1986 Dec;14(6):557-99. doi: 10.1007/BF01067965.
7
General method for assessing bioavailability of drugs undergoing reversible metabolism in a linear system.
J Pharm Sci. 1986 Aug;75(8):820-1. doi: 10.1002/jps.2600750822.
8
Estimation of the rates of available fraction for some 4-substituted acetophenone derivatives in the rat: reversible drug-metabolite pharmacokinetics.
Chem Pharm Bull (Tokyo). 1988 Nov;36(11):4612-8. doi: 10.1248/cpb.36.4612.
9
Mean residence time for drugs subject to reversible metabolism.
J Pharm Pharmacol. 1987 Jul;39(7):565-7. doi: 10.1111/j.2042-7158.1987.tb03181.x.
10
Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.用于估算经历可逆代谢的药物在体内的稳态分布容积和平均驻留时间的恒速静脉输注方法。
Pharm Res. 1990 Jun;7(6):628-32. doi: 10.1023/a:1015874329265.